Singapore markets closed

Straits Times Index
3,292.93
-3.96(-0.12%)
Nikkei
38,236.07
-37.98(-0.10%)
Hang Seng
18,475.92
+268.79(+1.48%)
FTSE 100
8,213.88
+41.73(+0.51%)
Bitcoin USD
60,260.57
+1,451.93(+2.47%)
CMC Crypto 200
1,279.35
+2.37(+0.19%)

GILD Jan 2025 80.000 put

OPR - OPR Delayed price. Currency in USD

Add to watchlist

15.54

0.00

(0.00%)

As of 11:47AM EDT. Market open.

Loading interactive chart…

Zacks
The Zacks Analyst Blog Highlights Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine
Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine are included in this Analyst Blog.
Zacks
Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More
Deciphera Pharmaceuticals, Inc. (DCPH) and GSK are in focus on acquisition news and Q1 earnings, respectively.
Business Wire
Gilead Sciences to Present at Upcoming Investor Conferences
FOSTER CITY, Calif., April 30, 2024--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences: